Tuesday, September 24, 2019
- 1:45pm-3:15pm
-
Genotype-phenotype relations for the isolated Dystonia Genes TOR1A, THAP1, GNAL, ANO3, KMT2B, PRKRA and HPCA: MDSGene Systematic Review
Dystonia · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Ginsenoside Rb1 Prevents MPTP-Induced Changes in Hippocampal Memory via Regulation of the α-Synuclein/PSD-95 Pathway
Neurophysiology · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Glabellar tap predicts dopamine transporter deficiency in parkinsonism
Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
GluRδ2 protein reduction in cerebellar Purkinje cells contributes to the pathogenesis of essential tremor
Tremor · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
GNAO1 gene mutation: generalized dystonia without epilepsy.
Dystonia · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Goal setting for botulinum toxin injections: Impact of the Upper Limb International Spasticity (ULIS) programme
Spasticity · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
GPi DBS does not affect sensory thresholds in hereditary/idiopathic dystonia
Dystonia · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Gray matter atrophy in Parkinson’s disease and freezing of gait assessed using surface-based algorithm – results of an open, longitudinal, single-centre study
Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
Guided Self-rehabilitation Contracts combined with simultaneous injections of abobotulinumtoxinA into upper and lower limbs in spastic hemiparesis: baseline data from the ENGAGE study
Spasticity · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Harmonics: A reliable marker in tremor analysis for the differential diagnosis of Parkinson’s disease and multiple system atrophy
Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3
- «Previous Page
- 1
- …
- 29
- 30
- 31
- 32
- 33
- …
- 69
- Next Page»